Advanced Wound Care


  • Contains Active Leptospermum Honey
  • Helps Autolytic Debridement
  • Quickly Deodorizes Wounds
  • Promotes Wound Healing
MEDIHONEY® Wound and Burn Dressings


Global leading medical-grade Active Leptospermum Honey base for advanced wound care products


Why Medihoney®?

Because it…

  • quickly deodorizes wounds
  • helps autolytic debridement
  • destroys and prevents the formation of biofilms
  • promotes cell proliferation
  • destroys free radicals
  • stimulates the release of TNFα in monocytes

MEDIHONEY® can be applied to almost any type of wound from light exudate to infected wounds with heavy exudate.


Why Active Leptospermum Honey?

Active Leptospermum Honey is the most studied commercially available medical grade honey that offers versatility, safety, and effectiveness for managing challenging wounds and helping with the removal of necrotic tissue.


What is Active Leptospermum Honey (ALH)?

  • The most studied species of honey for the management of wounds and burns
  • Also known as Manuka honey, it is derived from the pollen and nectar of a specific Leptospermum species of plant in New Zealand
  • Unique among all types of honey, it maintains its effectiveness even in the presence of wound fluid
  • The only species of honey that has been shown in randomized controlled studies to help wounds that have stalled under first-line treatment to progress towards healing


MEDIHONEY® - Superior Sourcing, Rigorous Processing

  • Controlled against a rigorous set of systems and standards, and demonstrates product consistency from batch-to-batch
  • Sterilized by gamma irradiation, destroying any bacterial spores without loss of product effectiveness
  • Comes from a traceable source and is free of pesticides and antibiotics


How MEDIHONEY® helps to promote healing:

  • Promotes a moisture-balanced environment conducive to wound healing
  • Multiple Mechanisms of Action (MOA’s) help to manage and gain control over the wound environment
  • Assists in autolytic debridement due to high osmolarity
  • Promotes a constant outflow of lymph fluid helping to lift necrotic tissue from the wound environment
  • Helps to lower pH levels within the wound, decreasing protease activity
  • Is non-toxic, natural, and safe
  • Easy to use, with the potential for extended wear times



Dressings that can be used from the start of the wound through to closure, with a variety of dressing formats to help make wound management easier.

MEDIHONEY® dressings are available in several formats, including:


MEDIHONEY® HCS (Leptospermum Honey content – 63%)

Combines the healing properties of Leptospermum Honey with the fluid handling capability of Super Absorbent Polyment (SAP) technology.
  • Absorbs 2.5x the amount of fluid of leading hydrocolloids
  • Is cooling and soothing upon application
  • Two versions: Adhesive and non-adhesive
  • Both versions absorb light to moderate amounts of exudate

Usage suggestions:
For dry to moderately exuding superficial to partial thickness wounds.

Catalog Number Description
31622 2.4” x 2.4”  10/box, 5 boxes/case
31644 4.33” x 4.33”  10/box, 5 boxes/case
31722 2.8" x 2.8"  10/box, 5 boxes/case (4.3" x 4.3" with adhesive border)
31744 4 ½" x 4 ½"  10/box, 5 boxes/case (6" x 6" with adhesive border)



MEDIHONEY® Gel (Active Leptospermum Honey content – 80%)

80% Active Leptospermum Honey and 20% Natural gelling agents.
  • Provides increased stability at the site of the wound due to its natural gelling agents.

Usage suggestions:
This natural and non-toxic honey dressing can be used safely on superficial to full thickness wounds.

Catalog Number Description
31805 0.5 oz tube 10/box, 4 boxes/case
31815 1.5 oz tube 1/box, 12 boxes/case


MEDIHONEY® Paste (Active Leptospermum Honey content – 100%)

For use in hard-to-dress wounds and other wounds that would normally require a gel or paste.
  • This all natural and non-toxic honey dressing can be used safely in tunneled wounds or wounds with undermining.
  • An optional accessory applicator tip comes in each box, to help facilitate application into tough-to-reach areas.

Usage suggestions:
This all natural and non-toxic honey dressing can be used safely in tunneled wounds or wounds with undermining.
An optional accessory applicator tip comes in each box, to help facilitate application into tough-to-reach areas.

Catalog Number Description
31505 2.4” x 2.4”  10/box, 5 boxes/case
31515 4.33” x 4.33”  10/box, 5 boxes/case
31535 2.8" x 2.8"  10/box, 5 boxes/case (4.3" x 4.3" with adhesive border)


MEDIHONEY® Calcium Alginate (Active Leptospermum Honey content – 95%)

Honey impregnated into a calcium alginate dressing.
  • As wound fluid enters the dressing, the honey is released while the dressing absorbs and forms a gel.
Usage suggestions: Used in the same fashion as a typical calcium alginate or other gelling fiber dressing.
Catalog Number Description
31012 Rope Dressing  ¾" x 12" (0.6 x 30.5 cm), package of 5 dressings, 4 packages/case
31022 Dressing 2" x 2" (5 x 5 cm), package of 10 dressings, 10 packs/case
31045 Dressing 4" x 5" (10 x 13 cm), package of 10 dressings, 5 packs/case


MEDIHONEY® Honeycolloid™ (Active Leptospermum Honey content – 80%)

The honey colloid pad will form a gel as it warms up with body temperature and as it comes into contact with wound fluid.
  • Two versions: Adhesive and non-adhesive
  • The adhesive version is occlusive like a traditional hydrocolloid, having a thin film backing and adhesive border.
  • The non-adhesive version is not occlusive, and requires a secondary dressing to hold in place.
  • Both versions absorb light to moderate amounts of exudates.
  • The non-adhesive version can be used similarly to an alginate or a hydrocolloid paste to either cover or fill a partial-to-full thickness wound.

Usage suggestions:
For lightly to moderately exuding superficial to partial thickness wounds. The non-adhesive version can be used similarly to an alginate or a hydrocolloid paste to either cover or fill a partial-to-full thickness wound.

Catalog Number Description
31222 Dressing 2" x 2" (5 x 5 cm), package of 10 dressings, 10 packages/case
31245 Dressing 4" x 5" (10 x 13 cm), package of 10 dressings, 5 packages/case
31422 2" x 2" 10/box, 10 boxes/case (3 ½" x 3 ½" with adhesive border)
31445 4 ½" x 4 ½" 10/box, 5 boxes/case (6" x 6" with adhesive border)

Distributed by Victus, Inc.

All technical information obtained from manufacturer’s website and technical sheets.




Do not use MEDIHONEY®:

  • On third degree burns.
  • With patients that have a known sensitivity to honey or any other component parts specific to each dressing (please see package insert for more information).
  • To control heavy bleeding.



  • If the dressing is not easily removed, soak with sterile saline or water until it is removed without difficulty.
  • Due to the dressing’s low pH, some patients may notice a slight transient stinging. If stinging does not stop or persists and cannot be managed with an analgesic, remove dressing, cleanse area, and discontinue the use of  MEDIHONEY® dressing.
  • During initial use of the dressing (depending on wound exudate levels, interstitial fluid, and edema surrounding the wound), the dressings high osmotic potential may contribute to increased exudate, which could lead to maceration if the excess moisture is not managed appropriately. Manage additional moisture by adding an absorptive cover dressing and/or adjusting the frequency of dressing change.
  • During the healing process it is common for non-viable tissue to be removed from the wound resulting in an initial increase in wound size. Although an initial increase in wound size may be attributed to the normal removal ofnon-viable tissue, consult a healthcare professional if the wound continues to grow larger after the first few dressing changes.



What is active Leptospermum honey?

It is the most studied honey for the management of wounds and burns, and is ideal for use in injuries requiring medical-grade honey. Active Leptospermum honey is, with calcium alginate, the main component of the MEDIHONEY® dressings for wound care.


With what type of injuries can I use MEDIHONEY®?
MEDIHONEY® can be used in a variety of hard to heal wounds, whether acute or chronic, including:

  • Diabetic foot ulcers
  • Venous stasis leg ulcers
  • Arterial leg ulcers
  • Leg ulcers of mixed etiology
  • Pressure ulcers (Stages I - IV)
  • 1st and 2nd degree burns
  • Donor sites
  • Traumatic and surgical wounds


Is the concentration of hydrogen peroxide produced cytotoxic?
According to the studies performed, the concentration of peroxide are below the risk level for cytotoxicity. The release of hydrogen peroxide occurs in a constant and continuous manner.


Is MEDIHONEY a fungicide?
Yes it is.


How does it destroy the fungi?
Leptospermum Honey has broad-spectrum effects. It is effective against gram-negative and gram-positive, both anaerobic and aerobic, as well as against fungi and protozoans. Leptospermum Honey has been shown to inhibit more than 80 different species of microorganisms (bacteria, dermatophytes, fungi and yeasts, protozoans and viruses). The action on microorganisms, as mentioned earlier, is a combination of several factors including production of peroxide, reduced pH and osmotic action.


How is MEDIHONEY® classifed and what activity level does it have?
MEDIHONEY® is evaluated against rigorous tests and standard patterns, including a classification to quantify the activity level. This standardization classifies all the Leptospermum honeys verifying its activity level and the special characteristics that makes them beneficial for the management of wounds and burns, according to the following classification:

  • Activity Rating 0: No activity.
  • Activity Rating 1 to 12: Moderate Activity.
  • Activity Rating 13 or higher: High Activity.

The Leptospermum honey used in MEDIHONEY® preparations is Activity Rating 15 or higher.


How does it favor the immune system?
MEDIHONEY® promotes the growth of macrophages, keratinocytes and fibroblasts (immune cells), exerting anti-inflammatory and immunomodulation activities. It also stimulates the formation of TNF? (Tumor Necrosis Factor - alpha) in monocytes. This is a cytokine that acts as a mediator and activator of neutrophils and is one of the major mediators of the acute inflammatory response. In addition, the 5.8-kDa component of Leptospermum Honey stimulates immune cells via TLR4.

  • Acton C.; MEDIHONEY®: A complete wound bed preparation product. Br J Nurs. 2008, 17 (11): S44, S46-S48. 
  • Blaser G, Santos K, Bode U, Vetter H, Simon A., Effect of medical honey on wounds colonised or infected with MRSA. J Wound Care. 2007, 16 (8):325-328. 
  • Cooper R.; Using honey to inhibit wound pathogens. Nurs Times. 2008, 104 (3) :46,48-49. 
  • Cooper RA, Molan PC, Harding KG; The sensitivity to honey of Gram-positive cocci of clinical significance isolated from wounds. J Appl Microbiol. 2002, 93 (5):857-863. 
  • Cooper RA, Molan PC, Krishnamoorthy L, Harding KG; Manuka honey used to heal a recalcitrant surgical wound. Eur J Clin Microbiol Infect Dis. 2001, 20 (10):758-759.
  • Cutting KF, Honey and contemporary wound care: an overview. Ostomy Wound Manage. 2007, 53 (11):49-54. 
  • George NM, Cutting KF; Antibacterial honey (MEDIHONEY™): in-vitro activity against clinical isolates of MRSA, VRE, and Other Multiresis tant gram-negative organisms including Pseudomonas aeruginosa. Wounds. 2007, 19 (9):231-236.
  • Gethin G, Cowman S.; sloughy Bacteriological changes in venous leg ulcers treated with manuka honey or hydrogel: an RCT. J Wound Care. 2008, 17 (6):241-244 ,246-247. 
  • Gethin G, Cowman S.; Case series of use of Manuka honey in leg ulceration. Int Wound J. 2005, 2:10-15.
  • Gethin G, Cowman S.; Manuka honey vs.. hydrogel - a prospective, open label, multicentre, randomized controlled trial to compare desloughing efficacy and healing outcomes in venous ulcers. J Clin Nurs. 2009 Feb; 18 (3) :466-74. 
  • Gethin GT, Cowman S, Conroy RM, The impact of Manuka honey dressings on the surface pH of chronic wounds. Int Wound J. 2008, 5 (2):185-194. 
  • Graham T., T. Bateman, The use of MEDIHONEY™ antibacterial wound gel on surgical wounds post-CABG. Wounds UK. 2007, 3 (3):76-83.
  • Henriques A, Jackson S, Cooper R, Burton N. Free radical production and quenching in honeys with wound healing potential. J Antimicrob Chemother. 2006, 58 (4):773-777. 
  • Johnson DW, van Eps C, Mudge DW, et Al, randomized, controlled trial of topical exit-site application of honey (MEDIHONEY) versus mupirocin for the prevention of catheter-associated infections in hemodialysis patients. J Am Soc Nephrol. 2005, 16 (5) :1456-1462. 
  • Natarajan S, Williamson D., Gray J., Harding KG, Cooper RA; Healing of an MRSA-colonized, hydroxyurea-induced leg ulcer with honey. J Dermatol Treat. 2001; 12:33-36.
  • Simon A, Sofka K, Wiszniewsky G., G. Blaser, U. Bode, Fleischhacker G. Wound care with antibacterial honey (MEDIHONEY) in pediatric hematology-oncology. Support Care Cancer. 2006, 14 (1) :91-97. 
  • AJ Tonks, E. Dudley, NG Porter, et Al, A 5.8-kDa component of manuka honey stimulates immune cells via TLR4. J Leukoc Biol. 2007, 82 (5):1147-1155. 
  • Van der Weyden EA; The use of honey for the treatment of two patients with pressure ulcers. Br J Community Nurs. 2003, 8 (12): S14-S20. 
  • Visavadia BG, Honeysett J, Danford MH; Manuka honey dressing: An effective treatment for chronic wound infections. Br J Oral Maxillofac Surg. 2006. 
  • White RJ, Cutting K, Kingsley A.; Topical antimicrobials in the control of wound bioburden. Ostomy Wound Manage. 2006, 52 (8) :26-58
  • Nancy Chaiken, ANP-C, CWOCN, Swedish Covenant Hospital, Chicago, IL, a study of various etiologies and co-morbidities